Related Experiment Video
Updated: Feb 17, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
Lucía Barbier-Torres1, Paula Iruzubieta1,2, David Fernández-Ramos1
1Liver Disease Laboratory and Liver Metabolism Laboratory, CIC bioGUNE, CIBERehd, Bizkaia Science and Technology Park, Derio, 48160, Bizkaia, Spain.
Abstract:
Acetaminophen (APAP) is the active component of many medications used to treat pain and fever worldwide. Its overuse provokes liver injury and it is the second most common cause of liver failure. Mitochondrial dysfunction contributes to APAP-induced liver injury but the mechanism by which APAP causes hepatocyte toxicity is not completely understood. Therefore, we lack efficient therapeutic strategies to treat this pathology. Here we show that APAP interferes with the formation of mitochondrial respiratory supercomplexes via the mitochondrial negative regulator MCJ, and leads to decreased production of ATP and increased generation of ROS. In vivo treatment with an inhibitor of MCJ expression protects liver from acetaminophen-induced liver injury at a time when N-acetylcysteine, the standard therapy, has no efficacy. We also show elevated levels of MCJ in the liver of patients with acetaminophen overdose. We suggest that MCJ may represent a therapeutic target to prevent and rescue liver injury caused by acetaminophen.
Insights
Acetaminophen (APAP) overdose causes liver injury by disrupting mitochondrial function via MCJ. Inhibiting MCJ protects the liver, offering a potential new therapy for APAP-induced liver damage.
Area of Science:
- Hepatology
- Mitochondrial Biology
- Toxicology
Background:
- Acetaminophen (APAP) overdose is a leading cause of acute liver failure worldwide.
- Mitochondrial dysfunction is implicated in APAP-induced liver injury, but mechanisms remain unclear.
- Current therapies like N-acetylcysteine are not always effective.
Purpose of the Study:
- To elucidate the mechanism of APAP-induced hepatotoxicity.
- To identify novel therapeutic targets for APAP-induced liver injury.
- To evaluate the role of mitochondrial protein MCJ in APAP toxicity.
Main Methods:
- Investigated APAP's effect on mitochondrial respiratory supercomplexes in vitro and in vivo.
- Utilized MCJ inhibitors in animal models of APAP overdose.
- Analyzed MCJ levels in liver samples from patients with acetaminophen overdose.
Main Results:
- APAP disrupts mitochondrial respiratory supercomplex formation by interacting with MCJ.
- This disruption leads to reduced ATP production and increased reactive oxygen species (ROS) generation.
- Inhibition of MCJ protected against APAP-induced liver injury, outperforming N-acetylcysteine.
- Elevated MCJ levels were observed in human acetaminophen overdose cases.
Conclusions:
- MCJ plays a critical role in APAP-induced hepatotoxicity.
- Targeting MCJ represents a promising therapeutic strategy for acetaminophen overdose.
- MCJ inhibition offers a potential alternative or adjunct therapy for liver injury prevention and treatment.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Mitochondrial Membranes
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

